{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Express Preemption For a De Novo Device With Special Controls Should Have Been The End",
"url": "https://www.lexblog.com/2026/09/17/express-preemption-for-a-de-novo-device-with-special-controls-should-have-been-the-end/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-B8BGS1SH",
"url": "https://www.lexblog.com/lib/B8BGS1SH/"
},
"datePublished": "2026-09-17T06:43:00-04:00",
"dateModified": "2026-09-17T09:52:32-04:00",
"author": {
"@type": "Person",
"name": "Eric Alexander"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Drug & Device Law Blogging Team"
},
"organizationScope": "at-publication",
"isPartOf": "Drug & Device Law",
"about": "Administrative and Regulatory ยท Health Care and Life Sciences",
"sourceUrl": "https://www.druganddevicelawblog.com/?p=47123",
"sourceStability": "may-move"
}